The National Pharmaceutical Council (NPC) and AcademyHealth generated potential strategies for boosting transparency and credibility for studies that utilize real-world data (RWD).
Transparency, according to a NPC blog post, remains a key obstacle for more widespread acceptance of studies conducted with RWD.
“Both NPC and AcademyHealth recognized that by making RWE research methods more transparent, they could improve efforts to reproduce studies, disclose key study methods and reduce skepticism about the ultimate results,” the blog post states.
To read the NPC blog post, click here.
